Ambrosia Biosciences Inc.
Small molecule therapies for obesity and metabolic disorders, delivered orally
38 employees · est. 2024 · Boulder, United States
Lumen Bioscience
Our patented technology allows us to use the well-known food algae spirulina to deliver therapeutic proteins.
90 employees · est. 2017 · Seattle, United States
Lumen Bioscience is the older company (2024 vs 2017); Lumen Bioscience is the larger of the two.
Side-by-Side Comparison
| Metric | Ambrosia Biosciences Inc. | Lumen Bioscience |
|---|---|---|
| Founded | ||
| Founded | 2024 | 2017 older |
| Headquarters | ||
| Headquarters | Boulder, United States | Seattle, United States |
| Employees | ||
| Employees | 38 | 90 larger |
| Industry | ||
| Industry | Biotechnology, Pharmaceutical | Biopharma, Biotechnology, Life Sciences |
| Funding Stage | ||
| Funding Stage | Series B | Grant |
| Total Funding | ||
| Total Funding | $125.00M | $66.95M |
| Funding Rounds | ||
| Funding Rounds | 3 | 9 |
| Services | ||
| Services | Development of small molecule-based therapies, Drug discovery using structure-based approaches, Rapid iteration from initial discovery to IND filings, Discovery of orally delivered therapies for obesity | Not tracked yet |
| Target Customers | ||
| Target Customers | Biotechnology investors, Pharmaceutical industry partners, Patients with obesity and metabolic disorders, Scientific community focusing on metabolic and cardiometabolic conditions | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Small Molecule Therapies, Obesity Treatment, Metabolic Disorders, Drug Discovery, Orally Delivered Drugs, GLP-1, Incretin Hormones, Class B GPCRs, Therapeutics Development, Pharmaceutical Innovation, Novel Drug Compounds | Therapeutic Proteins, Clinical-Stage, Oral Antibody Therapeutics, Topically Delivered Drugs, Mucosally Delivered Drugs, Industrial Biotechnology, Cyanobacteria, Pigments, Animal Health |
| Website | ||
| Website | ambrosiabiosciences.com | lumen.bio |
About Ambrosia Biosciences Inc.
Ambrosia Biosciences Inc., founded in 2024, is positioned at the forefront of tackling global health challenges in Biotechnology and Pharmaceutical industries. The company is pioneering the development of orally delivered, small molecule-based therapies to address pressing issues such as obesity and...
About Lumen Bioscience
Lumen Bioscience, founded in 2017, is a biopharmaceutical and biotechnology company based in the United States. The company's patented technology harnesses the potential of the renowned food algae spirulina to develop oral antibody therapeutics. This innovative approach has garnered attention and su...
We will tell you when either one moves
BounceWatch watches Ambrosia Biosciences Inc. and Lumen Bioscience for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Ambrosia Biosciences I... and Lumen Bioscience — by email.
Frequently Asked Questions
Compare Ambrosia Biosciences Inc. with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Ambrosia Biosciences Inc. on 9 Jun 2026, and Lumen Bioscience on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.